Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Building and Evaluating a Stratified Prostate Cancer Pathway (BeSpoke): the Impact of BeSpoke Decision Support in Patients With Newly Diagnosed Localised Prostate Cancer - a Single-blind Randomised Controlled Trial With Mixed Method Analysis

NCT07135271 is registered in ClinicalTrials.gov with University College, London as lead sponsor.

NCT NCT07135271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07135271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Building and Evaluating a Stratified Prostate Cancer Pathway (BeSpoke): the Impact of BeSpoke Decision Support in Patients With Newly Diagnosed Localised Prostate Cancer - a Single-blind Randomised Controlled Trial With Mixed Method Analysis
Lead sponsor
University College, London
Phase
Not applicable
Overall status
Recruiting
Start date
July 22, 2026
Completion date
December 31, 2028
Enrollment
346 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localised prostate cancer